Skip to main content

Table 1 Inclusion and exclusion criteria

From: Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial

Inclusion criteria Exclusion criteria
1. Histologically confirmed organ-confined unilateral PCa on TTMB (clinical stage T1c-T2b) 1. Bleeding disorder (prothrombin time > 14.5 s., partial thromboplastin time > 34 s.), Platelet Count <140/uL,
2. No ability to stop anticoagulant or antiplatelet therapy
2. Gleason sum score 6 or 7 3. Active (urinary tract) infection
4. History of bladder neck contracture
5. Major concurrent debilitating illness or ASA ≥4
6. Cardiac History
3. PSA <15 ng/mL or PSA >15 ng/mL counselled with caution 7. Inflammatory bowel disease
8. Major rectal surgery
9. Previous radiation to pelvis
10. Prior or concurrent malignancy
4. Life expectancy of >10 years, age ≥18 years 11. Biologic or chemotherapy for PCa
12. Hormonal therapy within last 6 months
13. Any resection or stenting of the prostate
14. Prostate calcification >5 mm